secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0000950170-24-074605
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 5.08, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health appoints Christina Valauri to board; Karen Drexler resigns effective Sep 30
--------------------------------------------------------------------------------

- Christina Valauri appointed director effective July 1, 2024; will chair Nominations & Corp Gov Committee.
- Valauri brings 30+ years capital markets experience; served as advisor since April 2023.
- Karen Drexler resigns as director effective Sep 30, 2024; will remain as strategic advisor.
- 2024 annual meeting set for Aug 9; record date June 17; shareholder proposals due June 27.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024074605/0000950170-24-074605-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017024074605/tivc-20240617.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-074605

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer